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Pearson correlations M1 alpha vs M1 bêta: 
 
-  Oral comprehension r= 0.80 
-  Oral expression r= 0.97 
-  Written comprehension r= 0.88 
-  Transpositions / transcoding r=0.98 
 
Summary  
•  Scores of the Screening BAT and both versions of 
MT86 are highly correlated for oral comprehension, 
oral expression and transpositions/transcoding. 
•  Correlations between the scores for written 
comprehension are weaker but still significant.  
•  The M1 alpha and the M1 bêta are highly correlated 
for the four skills tested. 
Conclusion 
•  The Screening BAT is a valid assessment tool for 
patients with aphasia. 
•  Short versions of aphasia tests are similar in validity 
to the long versions.  
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The	  Screening	  BAT	   is	   a	   simple	  and	  user-­‐friendly	  adaptaAon	  of	   the	  Bilingual	  Aphasia	  Test	   (BAT,	  Paradis	  &	   Libben,	  1987;	  Paradis,	   2011)	  developed	   for	  eﬃcient	  assessment	  of	  mulAlingual	   aphasic	  
paAents	  (Guihem	  et	  al,	  2013)	  and	  short	  enough	  for	  paAents	  in	  the	  acute	  phase	  or	  for	  quick	  screening	  in	  mulAlingual	  paAents.	  The	  test	  is	  based	  on	  17	  subtests	  out	  of	  the	  32	  of	  the	  BAT	  in	  order	  to	  
remain	  comprehensive	  enough	  for	  the	  establishment	  of	  the	  clinical	  report	  of	  the	  speech	  therapist.	  Despite	  a	  strong	  reducAon	  of	  the	  number	  of	  items	  from	  472	  in	  the	  BAT	  to	  117	  items,	  items	  with	  
increasing	  complexity	  were	  also	  maintained.	  All	  sAmuli	  are	  selected	  from	  the	  BAT	  and	  have	  been	  standardized	  with	  65	  naAve	  speakers	  of	  each	  language	  (Paradis	  &	  Libben,	  1987).	  Eleven	  languages	  
are	  freely	  available	  for	  the	  moment:	  Arabic,	  Catalan,	  English,	  French,	  German,	  Italian,	  Korean,	  Portuguese,	  Russian,	  Spanish	  and	  Turkish.	  Further	  versions	  can	  easily	  be	  adapted	  for	  the	  languages	  of	  
the	  BAT	  (haps://www.mcgill.ca/linguisAcs/research/bat)	  
	  
For	  eﬃcient	  use	   in	  clinical	  pracAce,	  however,	  more	   informaAon	   is	  needed	  on	  the	  validity	  of	  a	  new	  test.	  For	  speech	  therapists	  who	  use	  a	  more	  established	  test	  on	  a	  daily	  basis,	  empirical	  validity	  
obtained	  through	  the	  comparison	  of	  the	  new	  test	  with	  the	  established	  test	  serving	  as	  criterion	  are	  parAcularly	  interesAng.	  Ivanova	  &	  Hallowell	  (2013)	  state	  that	  criterion	  validity	  is	  evidenced	  through	  
high	  correlaAons	  between	  the	  scores	  on	  a	  new	  test	  and	  on	  a	  previously	  validated	  test.	  Indeed,	  the	  establishment	  of	  correlaAons	  between	  a	  new	  test	  in	  need	  of	  validaAon	  and	  an	  established	  test	  are	  
common	  in	  aphasiology	  and	  inspired	  the	  present	  study	  (e.g.,	  Flamand-­‐Roze	  et	  al.,	  2011	  ;	  	  Peristeri	  et	  Tspakini,	  2011	  ;	  Ozaeta	  et	  Kong,	  2012).	  
Comparing the Screening BAT to the Montreal-Toulouse 
Aphasia Battery MT86 (Nespoulous et al., 1986)  
References:	  	  
Béland,	  R.,	  Lecours,	  A.R.,	  Giroux,	  F.,	  Bois,	  M.	  (1993).	  The	  MT-­‐86β	  aphasia	  baaery:	  a	  subset	  of	  normaAve	  data	  in	  relaAon	  to	  age	  and	  level	  of	  school	  educaAon	  (Part	  II).	  Aphasiology,	  7(4)	  :	  359-­‐382.	  
Dordain,	  M.,	  Nespoulous,	  J-­‐L.,	  Bourdeau,	  M.	  et	  Lecours,	  A.R.	  (1983).	  Capacités	  verbales	  d'adultes	  normaux	  soumis	  à	  un	  protocole	  linguisAque	  de	  l'aphasie.	  Acta	  Neurologica	  Belgica,	  83	  (1)	  :	  5-­‐16.	  
Flamand-­‐Roze	  et	  al.	  (2011).	  ValidaAon	  of	  a	  new	  language	  screening	  tool	  for	  paAents	  with	  acute	  stroke	  :	  the	  Language	  Screening	  Test	  (LAST).	  Stroke,	  42:	  1224-­‐1229.	  
Guilhem,	  V.,	  Gomes,	  S.,	  Prod'homme,	  K.	  &	  Köpke,	  B.	  (2013).	  Le	  screening	  BAT	  :	  un	  ouAl	  d’évaluaAon	  rapide	  disponible	  en	  8	  langues	  et	  adaptable	  à	  toutes	  les	  langues	  du	  BAT.	  Rééduca>on	  orthophonique,	  253:	  121-­‐141.	  	  
Ivanova,	  M.	  V.,	  Hallowell,	  B.	  (2013).	  A	  tutorial	  on	  aphasia	  test	  development	  in	  any	  language	  :	  key	  substanAve	  and	  psychometric	  consideraAons.	  Aphasiology,	  27	  (8):	  891–920.	  
Muñoz	  M.L.	  &	  Marquardt	  T.P.	  (2008).	  The	  performance	  of	  neurologically	  normal	  bilingual	  speakers	  of	  Spanish	  and	  English	  on	  the	  short	  version	  of	  the	  Bilingual	  Aphasia	  Test.	  Aphasiology,	  22	  (1),	  3-­‐19.	  
Nespoulous,	  J-­‐L.,	  Lecours,	  A.R,	  Lafond,	  D.,	  Lemay,	  A.,	  Puel,	  M.,	  Joaneae,	  J.,	  Cot,	  F.	  et	  Rascol,	  A.	  1992).	  Protocole	  Montréal	  -­‐	  Toulouse	  d'examen	  linguis>que	  de	  l'aphasie.	  Isbergues	  :	  	  Ortho	  ÉdiAon.	  
Paradis,	  M.	  (2011).	  Principles	  underlying	  the	  Bilingual	  Aphasia	  Test	  (BAT)	  and	  its	  uses.	  Clinical	  LinguisAcs	  and	  PhoneAcs,	  25	  (6-­‐7),	  427-­‐443.	  
Paradis,	  M.	  &	  Libben,	  G.	  (1987).	  The	  assessment	  of	  bilingual	  aphasia.	  Hillsdale	  (NJ):	  Lawrence	  Earlbaum	  Associates.	  
Par>cipants:	  
	  
Inclusion	  :	  	  
-­‐  monolingual	  francophone	  aphasic	  
paAents	  in	  the	  chronic	  stage	  (>	  6	  
month)	  following	  lep	  hemisphere	  
stroke	  
-­‐  assessment	  with	  MT86,	  if	  any,	  >	  than	  
3	  month	  
Sample	  descrip>on	  :	  	  
-­‐  30	  aphasic	  paAents	  with	  chronic	  
aphasia	  (onset:	  M=8;7,	  range=	  8	  month	  -­‐	  
25	  years)	  
-­‐  17	  males	  and	  13	  females	  
-­‐  mean	  age	  66,4	  years	  (ET	  12,89;	  range=	  
48	  -­‐	  88	  years)	  
-­‐  all	  but	  4	  parAcipants	  (13%)	  had	  more	  
than	  9	  years	  of	  educaAon	  
-­‐  22	  present	  non	  ﬂuent	  aphasia	  (73%),	  
8	  ﬂuent	  aphasia	  (27%)	  
	  
Results: Pearson correlations 
Sciences of Aphasia, 
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Why	  MT86	  ?	  
	  
-­‐  The	  MT	  86	  exists	  in	  a	  long	  (M1bêta)	  and	  a	  short	  (M1alpha)	  version	  with	  content	  and	  
length	  similar	  to	  the	  BAT	  and	  the	  Screening	  BAT.	  
-­‐  NormalisaAon	  data	  are	  available	  for	  both	  versions	  (Béland	  et	  al,	  1993;	  Dordain	  et	  al,	  
1983)	  and	  both	  are	  extensively	  used	  for	  aphasia	  assessment	  in	  large	  parts	  of	  France,	  
Belgium	  and	  francophone	  Canada.	  
	  
Tabl.	  1	  Sub-­‐tests	  common	  to	  M1	  alpha,	  M1	  bêta	  and	  Screening	  BAT	  
	  
	  
Scores	  on	  subtests	  have	  been	  grouped	  following	  main	  skills	  involved:	  oral	  comprehension,	  
oral	  producAon,	  wriaen	  comprehension,	  transposiAon/transcoding.	  	  
Method	  
Procedure:	  
-­‐  All	  paAents	  were	  tested	  in	  2	  sessions	  in	  their	  homes	  
-­‐  Order	  of	  presentaAon	  of	  the	  diﬀerent	  tests	  was	  counterbalanced	  through	  cross-­‐over	  design	  





1# M" 50" R" 9"≥" non"fluent" 1";11" Ischemic"stroke"LH" yes"
2# F" 75" R" 9"≥" non"fluent" 6";10" Ischemic"stroke"LH" yes"
3# F" 75" R" 9"≥" non"fluent" 14" n.i." yes"
4# F" 51" R" 9"≥" non"fluent" 7" n.i." yes"
5# F" 48" R" 9"≥" fluent" 4";2" Ischemic"stroke"LH" no"
6# M" 81" R" 9"≥" non"fluent" 3";8" n.i." yes"
7# F" 63" R" 9"≥" fluent" 15" n.i." yes"
8# F" 53" R" 9"≥" fluent" 7" Ischemic"stroke"LH" yes"
9# M" 52" R" 9"≥" non"fluent" 25";1" n.i." yes"
10# M" 52" R" 9"≥" fluent" 8" n.i." yes"
11# M" 82" R" <"9" non"fluent" 4" Ischemic"sylvian"stroke"LH" yes"
12# M" 56" R" 9"≥" non"fluent" 2";2" Ischemic"sylvian"stroke"LH" yes"
13# F" 56" L" 9"≥" fluent" 1";3" n.i." no"
14# F" 68" R" 9"≥" non"fluent" 14" n.i." yes"
15# M" 81" R" <"9" non"fluent" 1";4" Ischemic"sylvian"stroke"LH" yes"
16# M" 57" R" 9"≥" non"fluent" 17" n.i." yes"
17# F" 67" R" 9"≥" non"fluent" 14" Ischemic"stroke"LH" no"
18# F" 50" L" 9"≥" non"fluent" 12";9" Ischemic"sylvian"stroke"LH" yes"
19# M" 66" R" 9"≥" fluent" 0";11" Ischemic"sylvian"stroke"LH" no"
20# M" 80" R" 9"≥" non"fluent" 9";9" Ischemic"sylvian"stroke"LH" no"
21# F" 49" L" 9"≥" fluent" 0";9" Ischemic"sylvian"stroke"LH" no"
22# M" 65" R" 9"≥" non"fluent" 3";10" Ischemic"stroke"LH" no"
23# M" 65" R" 9"≥" non"fluent" 5";10" Ischemic"stroke"LH" yes"
24# M" 87" R" 9"≥" non"fluent" 5";6" Ischemic"stroke"brainstem" no"
25# M" 72" R" <"9" non"fluent" 0";11" n.i." yes"
26# F" 73" R" 9"≥" non"fluent" 10";3" Ischemic"stroke"LH" yes"
27# F" 88" R" 9"≥" non"fluent" 0";9" Ischemic"sylvian"stroke"LH" yes"
28# M" 82" R" 9"≥" non"fluent" 1";5" Ischemic"sylvian"stroke"LH" yes"
29# M" 83" R" <"9" non"fluent" 5" Sylvian"stroke"LH" yes"
30# M" 66" R" 9"≥" fluent" 0";8" Ischemic"sylvian"stroke"LH" non"
 
Screening	  BAT	  vs.	  M1	  	  alpha	   Screening	  BAT	  vs.	  M1	  	  bêta	  
Screening BAT: contact 
bkopke@univ-tlse2.fr (Barbara Köpke) 
